Lauxera Capital Partners deepens stake in Natural Cycles with $53M secondary

What's the deal? Lauxera Capital PartnersDealroom has a profile for this one. Try Dealroom → has made a further investment in Natural Cycles AG, a Swiss-based women's health company, through US$34.3M secondary acquisition of shares. The deal, which brought together a group of international investors, marks a deepening of Lauxera's existing stake in the company.

NautaDutilh advised Lauxera on the Luxembourg law aspects of the transaction, alongside McDermott Will & Schulte on French law and Schellenberg Wittmer on Swiss law.

Why now? The investment reflects Lauxera's continued commitment to the women's health sector. As an existing investor in Natural Cycles, the firm used this secondary round to increase its position — a sign of confidence in the company's trajectory.

The signal: Natural Cycles, classified as a breakout-stage company and known as the world's first digital birth control method, represents a maturing femtech bet — and Lauxera's decision to deepen its position via secondary share acquisition rather than a fresh primary round suggests the fund sees near-term value inflection. Secondary transactions like this one are increasingly common when investors want to consolidate ownership in later-stage companies without triggering new dilution, pointing to growing liquidity options in a sector that has historically struggled with long exit timelines.

Read more: nautadutilh.com